Patent details

EP1689751 Title: 5,7-DIAMINOPYRAZOLO[4,3-D]PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1689751
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP04798876.1
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:

Dates

Filing date:
12/11/2004
Grant date:
20/10/2010
EP Publication Date:
20/10/2010
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/12/2018
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/10/2010
EP B1 Publication Date:
20/10/2010
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
15/12/2010
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/11/2024
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
20/10/2010
 
 

 

Name:
Pfizer Limited
Address:
Ramsgate Road, SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

From:
20/10/2010
 
 

 

Name:
Pfizer, Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
20/10/2010
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BELL, Andrew Simon, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

2

Name:
BROWN, David Graham, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

3

Name:
DACK, Kevin Neil, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

4

Name:
FOX, David Nathan A., Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

5

Name:
MARSH, Ian Roger, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

6

Name:
MORRELL, Andrew Ian, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

7

Name:
PALMER, Michael John, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

8

Name:
WINSLOW, Carol Ann, Pfizer Global R&D
Address:
SANDWICH, KENT CT13 9NJ, United Kingdom (GB)

Priority

Priority Patent Number:
0327319
Priority Date:
24/11/2003
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 487/04;
IPC or IDT classification:
A61K 31/505; A61P 9/08;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
27/19
Publication date:
03/07/2019
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
2011/01
Publication date:
05/01/2011
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
2010/36
Publication date:
27/10/2010
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201042
Publication date:
20/10/2010
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
14/11/2017
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
15/12/2010 Claims Translated claims 19 PDF /6/7/8/8/9/0504798876/docs/ep04798876.1_0_claims20101215.pdf
15/12/2010 Outgoing Correspondence Outgoing Letter 1 PDF /6/7/8/8/9/0504798876/docs/ep04798876.1_1_outgoingcorrespondence20101215.pdf
15/12/2010 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /6/7/8/8/9/0504798876/docs/ep04798876.1_2_incomingcorrespondencepaper20101215.pdf